921 Investors following Syncom Health. Share this News with them.
0
Like this story, share it with millions of investors on M3
Swastika Investmart neutral on Syncom Healthcare IPO
Swastika Investmart has come out with a research report on Syncom Healthcare IPO (initial public offering). The research firm remained neutral on the IPO.
Swastika Investmart has come out with a research report on Syncom Healthcare IPO (initial public offering). The research firm remained neutral on the IPO.
Indore based Syncom Healthcare, a company is in the business of manufacturing, marketing and distribution of pharmaceutical formulations under own brands of Ethical, OTC, Generic and Herbal market segment, opened its public issue of 75,00,000 equity shares of Rs 10 each for subscription. The issue will close on January 29.
Swastika Investmart report on Syncom Healthcare IPO -
Syncom Healthcare has shown good financial performance in past. Its net sales have been rising at a CAGR of 40.47% in past 4 completed years with 3-digit CAGR for net profit. But, CARE grading of Grade 2 adds a negative vibe to the IPO sentiments. So we remain neutral on the IPO, however, investors can arrive at their decision after doing a Peer Group comparison to invest into the company's IPO.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
